Neuberger Berman Group
AMAG

Neuberger Berman Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Neuberger Berman Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-549,465
Closed -$21.8M – 1593
2015
Q3 		$21.8M Buy
549,465
+533,260
+3,291% +$33.1M 0.03% 603
2015
Q2 		$1.12M Sell
16,205
-8,475
-34% -$533K ﹤0.01% 1186
2015
Q1 		$1.35M Sell
24,680
-46,400
-65% -$2.21M ﹤0.01% 1155
2014
Q4 		$3.03M Buy
71,080
+44,000
+162% +$1.59M ﹤0.01% 1018
2014
Q3 		$864K Buy
+27,080
New +$577K ﹤0.01% 1276

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group's AMAG Position: Q4 2015 in Review

Neuberger Berman Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 549,465 shares — an estimated $21.8M sold.

Neuberger Berman Group first reported a position in AMAG in Q3 2014 and held it in 5 quarters. The position peaked at $21.8M in Q3 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • Neuberger Berman Group reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Neuberger Berman Group sold 549,465 AMAG Pharmaceuticals shares in Q4 2015, an estimated $21.8M.
  • Neuberger Berman Group first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 5 quarters.
  • Neuberger Berman Group's AMAG Pharmaceuticals position peaked at $21.8M in Q3 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Neuberger Berman Group's 13F filing for Q4 2015, filed 28 Jan 2016.